AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...

Oppenheimer reiterated an Outperform rating on Veru Inc. (NASDAQ:VERU), which has seen remarkable momentum with a 200% return over the past year and a 96% gain year-to-date. Anticipation is building ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...